Recital 6, Regulation (EU) 2020/1737

In forcesince 14 Jul 2020

The misuse and abuse of MDMA and amphetamines are causing serious social and public health problems in some regions of the Union. Additionally, organised crime groups in the Union produce vast amounts of MDMA and amphetamines. Large quantities of MDMA and amphetamines are also exported to third countries.